insight.rpxcorp.com/litigation_documents/12985997

Novartis Pharmaceuticals Corporation (“Novartis”) by its attorneys hereby alleges as follows: NATURE OF ... Pharmaceutical Industries, Inc. and Sun Pharma Global FZE are wholly owned subsidiaries of ... See, e.g., Pharmacyclics LLC et al. v.

www.ftc.gov/enforcement/cases-proceedings/141-0134/sun-pharmaceutical-industries-ltd-et-al-matter

Mar 20, 2015 ... Torrent Pharmaceuticals Ltd., a global drug company based in India that markets generic drugs in the United States, will acquire the divested ...

www.eplawpatentblog.com/eplaw/2015/02/nl-novartis-v-sun-skinny-label-injunction.html

Feb 12, 2015 ... Sun Pharmaceutical Industries (Europe) B.V., Court of Appeal The Hague, The Netherlands, ... Appeal of The Hague held Sun liable for indirect infringement of Novartis' Swiss type claim ... Arca Printersupplies et al. .... Lely · Lentana · LEO Pharma · Les Laboratoires Servier · LG · Liability shipping company ...

www.ptablitigationblog.com/wp-content/uploads/2018/07/Novartis-v.-Apotex-Gilenya.pdf

Jul 11, 2018 ... Pharmaceutical Industries, Inc., and Sun Pharma Global FZE (collectively,. “Sun”) (IPR2017-01929 ... Patent 9,187,405 to Novartis Pharmaceuticals Corporation ( see Assignment ... According to Patent Owner, there are no other judicial or .... 11 Kappos et al., “A Placebo-Controlled Trial of Oral Fingolimod in.

www.barentskrans.nl/en/news/final-relief-judgment-enforcement-second-medical-use-patent

Apr 10, 2017 ... Novartis et al. ... In 2013, Sun won a tender organised by health insurance company VGZ ... In its final decision of 5 April, the District Court held that Novartis' patent had however been directly infringed because Sun knew, or in ...

patentdocs.typepad.com/files/sun-pharma_ipr2017-01929_institution.pdf

... INC., and. SUN PHARMA GLOBAL FZE,. Petitioner, v. NOVARTIS AG,. Patent Owner. ... Sun Pharmaceutical Industries, Ltd., Sun Pharmaceutical Industries,. Inc., and Sun ... In IPR2017-00854, Apotex, Inc. and Apotex Corp. (collectively, ... 5 Kappos et al., “A Placebo-Controlled Trial of Oral Fingolimod in Relapsing ...

www.bloomberg.com/news/articles/2018-07-19/novartis-sues-in-bid-to-block-generic-sales-of-best-selling-drug

Jul 19, 2018 ... The cases are Novartis Pharmaceuticals Corporation v. ... Sun Pharmaceutical Industries Ltd., 18-cv-1040; and Novartis Pharmaceuticals ...

economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/sun-rises-with-rd-and-bets-on-specialty-drugs/articleshow/64458050.cms

Jun 5, 2018 ... Sun Pharma- India's largest drug maker - is vying for its share in the ... When ET sought responses on its strategy, Sun Pharma the company ... Novartis, Eli Lilly are ensconced in the drug segment and Sun is ... area for a small entry into the US branded or specialty drugs business. .... Ltd. All rights reserved.

www.ded.uscourts.gov/sites/default/files/opinions/gms/2017/february/14-664.pdf

v. AUROBINDO PHARMA LTD., et al. Defendants. I. INTRODUCTION .... Sun Pharma Global FZE is a company organized and existing under the laws of the United ..... the clinic: Probiodrug's compound P32/98 and Novartis' compound NVP-.